FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET ANALYSIS

Key Developments

• In January 2023, Premier Research, a clinical research organization (CRO), and Centogene N.V., a global leader in genetic diagnostics, formed a strategic partnership to provide end-to-end support in rare disease clinical trials. This partnership intends to improve patient identification, stratification, recruitment, and enrollment, enhancing the chances of study success.
• In December 2022, Everest Clinical Research, a leading full-service contract research organization with extensive expertise in biostatistics and statistical programming, announced the acquisition of Brightech International, a leading CRO that provides complex, value-added biostatistics, programming, and clinical data management services.
• In November 2022, Excelya Group, a renowned CRO partner, announced the opening of a new office in Durham, North Carolina's Research Triangle Park. Excelya's new office, which has been in the U.S. since 2019, will help the company continue to grow and expand its capabilities in North America, allowing it to provide worldwide solutions across its Full-Service, Functional Service Provision, and Contract Staff Resourcing business models.
• In January 2021, ICON plc, a global provider of outsourced drug and device research and commercialization services, announced that it had provided clinical trial services to Pfizer, a multinational pharmaceutical company, and BioNTech SE, a biotechnology business, for their experimental COVID-19 vaccination project. Pfizer and BioNTech were the first to report positive efficacy results from a Phase 3, late-stage investigation of a COVID-19 vaccine, as well as to acquire Emergency Use Authorization from the U.S. Food and Drug Administration for individuals aged 16 and above.